MULTIFOCAL MOTOR NEUROPATHY (MMN)
Clinical trials for MULTIFOCAL MOTOR NEUROPATHY (MMN) explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL MOTOR NEUROPATHY (MMN) trials appear
Sign up with your email to follow new studies for MULTIFOCAL MOTOR NEUROPATHY (MMN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for nerve disease: long-term drug trial underway
Disease control OngoingThis study looks at the long-term safety and effects of a drug called ARGX-117 in adults with multifocal motor neuropathy, a condition that causes muscle weakness. About 51 people who completed an earlier trial will receive the drug intravenously over an extended period. The goal…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New drug TAK-771 aims to control rare nerve diseases in japanese patients
Disease control OngoingThis study tests a medicine called TAK-771 in 26 Japanese adults with two rare nerve conditions, CIDP and MMN, which cause weakness and numbness. The goal is to see if the drug can prevent relapses and improve hand strength over up to 45 months of treatment. Participants receive …
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 13, 2026 16:09 UTC